1. Home
  2. BLCO vs NOV Comparison

BLCO vs NOV Comparison

Compare BLCO & NOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • NOV
  • Stock Information
  • Founded
  • BLCO 1853
  • NOV 1862
  • Country
  • BLCO Canada
  • NOV United States
  • Employees
  • BLCO N/A
  • NOV N/A
  • Industry
  • BLCO Ophthalmic Goods
  • NOV Metal Fabrications
  • Sector
  • BLCO Health Care
  • NOV Industrials
  • Exchange
  • BLCO Nasdaq
  • NOV Nasdaq
  • Market Cap
  • BLCO 4.9B
  • NOV 4.9B
  • IPO Year
  • BLCO 2022
  • NOV 1996
  • Fundamental
  • Price
  • BLCO $13.72
  • NOV $12.80
  • Analyst Decision
  • BLCO Hold
  • NOV Buy
  • Analyst Count
  • BLCO 13
  • NOV 17
  • Target Price
  • BLCO $15.83
  • NOV $17.38
  • AVG Volume (30 Days)
  • BLCO 758.1K
  • NOV 4.5M
  • Earning Date
  • BLCO 07-30-2025
  • NOV 07-28-2025
  • Dividend Yield
  • BLCO N/A
  • NOV 2.34%
  • EPS Growth
  • BLCO N/A
  • NOV N/A
  • EPS
  • BLCO N/A
  • NOV 1.50
  • Revenue
  • BLCO $4,829,000,000.00
  • NOV $8,818,000,000.00
  • Revenue This Year
  • BLCO $6.97
  • NOV N/A
  • Revenue Next Year
  • BLCO $5.48
  • NOV $0.80
  • P/E Ratio
  • BLCO N/A
  • NOV $8.56
  • Revenue Growth
  • BLCO 11.94
  • NOV 0.48
  • 52 Week Low
  • BLCO $10.45
  • NOV $10.84
  • 52 Week High
  • BLCO $21.69
  • NOV $21.20
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 63.37
  • NOV 45.91
  • Support Level
  • BLCO $12.02
  • NOV $13.23
  • Resistance Level
  • BLCO $14.35
  • NOV $13.85
  • Average True Range (ATR)
  • BLCO 0.45
  • NOV 0.45
  • MACD
  • BLCO 0.06
  • NOV -0.02
  • Stochastic Oscillator
  • BLCO 72.96
  • NOV 33.12

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About NOV NOV Inc.

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.

Share on Social Networks: